Faculty:

Vic Velanovich, Tampa, FL

View Audio Recording

678. RISK FACTORS FOR REGROWTH AFTER NONOPERATIVE MANAGEMENT FOR RECTAL CANCER
Neal Bhutiani*, Kentaro Ochiai, Tsuyoshi Konishi, Oliver Peacock, Y. Nancy You, Brian K. Bednarski, Craig A. Messick, Atsushi Ikeda, Michael White, John M. Skibber, George J. Chang, Abhineet Uppal
Surgical Oncology, The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX

679. LONG-TERM RESULTS OF LAPAROSCOPIC HELLER-DOR FOR ESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION: A PROSPECTIVE CONTROLLED TRIAL
Francesca Forattini*, Luca Provenzano, Mario Costantini, Giulia Nezi, Giovanni Capovilla, Andrea Costantini, Lucia Moletta, Loredana Nicoletti, Michele Valmasoni, Renato Salvador
Department of Surgical, Oncological and Gastroenterological Sciences,, Universita degli Studi di Padova, Padova, Veneto, Italy

680. CARCINOEMBRYONIC ANTIGEN INCREASE AFTER PREOPERATIVE CHEMOTHERAPY DISCONTINUATION PREDICTS RECURRENCE AND WORSE SURVIVAL AFTER RESECTION OF COLORECTAL LIVER METASTASES
Antony Haddad*, Mateo Lendoire, Abhineet Uppal, Harufumi Maki, Reed I. Ayabe, Timothy E. Newhook, Yun Shin Chun, Ching-Wei D. Tzeng, Jean-Nicolas Vauthey, Hop S. Tran Cao
The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX

681. EXERCISE STIMULATES ANTITUMORAL IMMUNITY IN PANCREATIC DUCTAL ADENOCARCINOMA
Mansour E. Riachi*^1,2, Carolina G. Alcantara Hirsch^1,2, Anthony Sorrentino^1,2, Erica Ma¹, Beny Shapiro¹, Christopher L. Wolfgang^1,2, Dafna Bar-Sagi^1,2
1NYU Langone Health, New York, NY; ²New York University Grossman School of Medicine, New York, NY

682. COMPARISON OF ADAPTED ENHANCED RECOVERY AFTER SURGERY (ERAS) PATHWAY VERSUS STANDARD CARE IN PATIENTS UNDERGOING EMERGENCY ABDOMINAL SURGERY - A RANDOMIZED CONTROLLED TRIAL
Vikram Kate*¹, Likhita S. Singh¹, Gurushankari Balakrishnan², Sathasivam Sureshkumar¹, Amaranathan Anandhi¹, Thulasingam Mahalakshmy³, Pankaj Kundra^4
1Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India; ²Department of Surgical Oncology, Cancer institute (WIA), Adyar, Pondicherry, India; ³Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India; ⁴Department of Anaesthesia and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India

683. ENDOSCOPIC THERAPIES FOR POST-BARIATRIC GASTRIC SLEEVE LEAKS: A COMPREHENSIVE 10-YEAR ANALYSIS OF EFFICACY, SAFETY, AND OUTCOMES
Kimberly F. Schuster*^1,2, Cem Simsek³, Christopher C. Thompson^1
1Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, MA; ²Tufts University School of Medicine, Boston, MA; ³Hacettepe Universitesi Tip Fakultesi, Ankara, Ankara, Turkey

Sp773
INTRODUCTION OF SSAT PRESIDENT
Ranjan Sudan
Duke University Medical Center, Durham, NC

Sp774
PRESIDENTIAL ADDRESS: "Meaning"
Vic Velanovich
USF, Tampa, FL
View Presidential Address

Faculty:

Vic Velanovich, Tampa, FL

Sp849
ORATION TITLE: "Executive Brain Vitality"
Michael Hoffmann
University of Central Florida, Orange County, FL

Hepatobiliary Tract Moderators:	Allison Martin, Houston, TX Daniel Nelson, Houston, TX
Stomach/Bariatric/Metabolic Moderators:	Alex Escalona, Santiago, Chile Kaitlyn Kelly, Madison, WI

Authors available at their posters to answer questions 12:30 pm - 1:30 pm; posters on display 9:30 AM - 4 PM.

Moderators:

Haejin In, New Brunswick, NJ Alia Qureshi, Portland, OR

Sp923
WHY ARE DEI INITIATIVES IMPORTANT IN GI SURGERY?
Steven C. Stain
Surgery, Albany Medical College, Albany, NY

Sp924
HOW TO GET STARTED: TOP-DOWN APPROACH
Chelsea Dorsey
University of Chicago Division of the Biological Sciences, Chicago, IL

Sp925
HOW TO GET STARTED: DOWN-UP APPROACH
Prakash K. Pandalai
University of Kentucky, Lexington, KY

Sp926
RESEARCH EFFORTS TO DIVERSIFY THE WORKFORCE
Heather Yeo
Weill Cornell, New York, NY

Q&A PANEL DISCUSSION

Faculty:

Keiichi Akahoshi, Tokyo, Japan Louisa Bolm, Boston, MA Sajid Khan, New Haven, CT

816. FROM TRENDS TO TRAJECTORIES: A 5-YEAR NATIONWIDE ASSESSMENT OF OPEN AND MINIMALLY INVASIVE PANCREATICODUODENECTOMY
Bibek Aryal, Yue Yin, Edward A. Joseph*, Sricharan Chalikonda, David Bartlett, Casey Allen
Surgical Oncology, Allegheny Health Network, Pittsburgh, PA

817. ASSOCIATION OF PREOPERATIVE CHOLANGITIS WITH OUTCOMES AND EXPENDITURES AMONG PATIENTS UNDERGOING PANCREATICODUODENECTOMY
Zayed Rashid*, Selamawit Woldesenbet, Mujtaba Khalil, Muhammad Muntazir Mehdi Khan, Yutaka Endo, Diamantis Tsilimigras, Erryk Katayama, Muhammad Muntazir M. Khan, Abdullah Altaf, Mary Dillhoff, Timothy M. Pawlik
Surgery, The Ohio State Wexner Medical Center, Columbus, OH

818. STRATIFICATION OF MANAGEMENT OF POSTOPERATIVE FLUID COLLECTIONS BY POST-RECONSTRUCTION ANATOMIC ZONES IN PANCREATICODUODENECTOMY PATIENTS
Jean Namgoong*¹, Grace C. Bloomfield¹, Piyush Gupta², Aradhya Nigam², Vasalya Panchumarthi¹, Thomas Fishbein², Pejman Radkani², Emily R. Winslow^3
1Georgetown University School of Medicine, Washington, ; ²MedStar Georgetown University Hospital, Washington, ; ³University of Wisconsin-Madison, Madison, WI

819. CHYLE LEAK FOLLOWING PANCREATIC RESECTION: AN UNDERAPPRECIATED CAUSE OF DELAYED POSTOPERATIVE RECOVERY
Grace C. Bloomfield*¹, Jean Namgoong¹, Piyush Gupta², Aradhya Nigam², Thomas Fishbein², Pejman Radkani², Emily R. Winslow^2
1Medical Student, Georgetown University School of Medicine, Washington, ; ²Georgetown University Medical Center, Washington,

820. FASTING RELATED AUTOPHAGY DECREASES THE SEVERITY OF ACUTE PANCREATITIS IN A RODENT MODEL OF SEVERE DISEASE
Marcel C C. Machado*, Marcia K. Koike, Denise F. Barbeiro, Francisco G. Soriano
University of São Paulo - School of Medicine, São Paulo, Brazil

821. QUALITY OF LIFE AND SOCIAL HEALTH IN PATIENTS AFTER PANCREATIC SURGERY
Nicholas Galouzis*, Maria K. Fotinos, Evelyn V. Alexander, Mohammad Khreiss, Carrie Luu, Lusine Mesropyan, Taylor S. Riall
Department of Surgery, Banner - University Medical Center Tucson, Tucson, AZ

822. READMISSION AFTER DISTAL PANCREATECTOMY FOR CHRONIC PANCREATITIS: COMMON AND CONSEQUENTIAL
Katelyn Flick*, Kyle A. Lewellen, James Butler, Eugene P. Ceppa, Ryan J. Ellis, Michael G. House, Trang Nguyen, Alexandra M. Roch, C. Max Schmidt, Nicholas J. Zyromski, Thomas K. Maatman
Indiana University School of Medicine, Indianapolis, IN

823. TOTAL NEOADJUVANT THERAPY IN DISTAL PANCREATIC ADENOCARCINOMA: DOES LOCATION IMPACT THERAPY RESPONSE?
Andrew B. Crocker*¹, Maryclare E. Taylor¹, Emily Papai¹, Max Perilstein², Malek Maddah², Karen Ruth¹, Anthony Villano¹, Sanjay S. Reddy^1
1Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA; ²Lewis Katz School of Medicine at Temple University, Philadelphia, PA

824. SBRT AFTER NEOADJUVANT CHEMOTHERAPY (NAC) FOR LOCALLY ADVANCED PANCREATIC CANCER (LAPC): PRELIMINARY INSTITUTIONAL RESULTS
Aikaterini Dedeilia*¹, Georgios Kritselis³, Nikiforos Ballian², Nikolaos Giakoumakis², Grigorios Tsiotos^2
1Surgery, Massachusetts General Hospital, Boston, MA; ²Mitera-Hygeia Hospital, Department of Surgery, Marousi, Greece; ³Mitera-Hygeia Hospital, Department of Radiation Oncology, Marousi, Greece

825. ASSESSING THE DIAGNOSTIC CONCORDANCE BETWEEN SURGEONS AND RADIOLOGISTS IN PANCREATIC CYST IMAGING
Gerik Cervantes*¹, juan malo², Houssam Osman², D Rohan Jeyarajah^2
1Texas Christian University Anne Burnett Marion School of Medicine, Fort Worth, TX; ²Methodist Richardson Medical Center, Richardson, TX

826. COMPARATIVE ANALYSIS OF LAPAROSCOPIC AND ROBOTIC DISTAL PANCREATECTOMY: BALANCING PERIOPERATIVE OUTCOMES AND COSTS
Edward A. Joseph*¹, Bibek Aryal¹, Tyson Barrett², Patrick Wagner¹, David Bartlett¹, Sricharan Chalikonda¹, Casey Allen^1
1Surgical Oncology, Allegheny Health Network, Pittsburgh, PA; ²Highmark Health, Pittsburgh, PA

827. DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE AFTER PANCREATICODUODENECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Ronnakorn Kongsakon*, Wasit Wongtrakul, Khemajira Karaketklang, Nonthalee Pausawasdi, Phunchai Charatcharoenwitthaya
Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok, Thailand

828. NEOADJUVANT CHEMOTHERAPY VERSUS UPFRONT SURGERY IN RESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA: A NATIONAL CANCER DATABASE INTENTION-TO-TREAT ANALYSIS
Joanna T. Buchheit*, Cynthia E. Burke, Charles C. Vining, Rushin D. Brahmbhatt, June S. Peng
Penn State College of Medicine, Hershey, PA

829. UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?
Maryclare E. Taylor*^1,2, Andrew B. Crocker², Emily Papai^1,2, Max Perilstein¹, Malek Maddah¹, Karen Ruth², Anthony Villano², Sanjay S. Reddy^2
1Surgery, Temple University Hospital, Philadelphia, PA; ²Fox Chase Cancer Center, Philadelphia, PA

830. COMPARING ONCOLOGIC AND SURGICAL OUTCOMES OF ROBOTIC AND LAPAROSCOPIC PANCREATICODUODENECTOMY: A PROPENSITY-MATCHED ANALYSIS
Chase J. Wehrle*¹, Jenny H. Chang¹, Abby Gross¹, Kimberly P. Woo¹, Robert Naples¹, Kathryn A. Stackhouse¹, Fadi Dahdaleh², Toms Augustin¹, Daniel Joyce¹, Robert Simon¹, R Matthew Walsh¹, Samer A. Naffouje^1
1Cleveland Clinic, Cleveland, OH; ²Edward Elmhurst Health Marquardt Memorial Library, Elmhurst, IL

831. IMPACT OF INSTITUTIONAL RADIOTHERAPY VOLUME ON POSTOPERATIVE AND ONCOLOGIC OUTCOMES AFTER NEOADJUVANT RADIATION FOR PANCREATIC CANCER
Raja R. Narayan*^1,2, Anne Pannekoek¹, Mengyuan Ruan¹, Ritchell van Dams^1,2, George Molina^1,2
1Surgery, Brigham and Women's Hospital, Boston, MA; ²Dana-Farber/Harvard Cancer Center, Boston, MA

Moderators:

Antonio Picon, Irving, NY Yuki Harata, Tokyo, Japan Victoria Gershuni, St. Louis, MO

832. CAUSES FOR REOPERATION AFTER GASTRIC NEUROSTIMULATOR IMPLANTATION
Katherine Englander*, Samer Ganam, Tejasvi Paturu, Joseph Sujka, Vic Velanovich
USF, Tampa, FL

833. RESTORE OR RENOVATE? REVISIONAL ENDOSCOPIC SLEEVE GASTROPLASTY (R-ESG) VERSUS (RYGB) ROUX-EN-Y GASTRIC BYPASS FOR WEIGHT REGAIN FOLLOWING SLEEVE GASTRECTOMY (SG)
Abdellah Hedjoudje*¹, Anna C. Hoff², Gabriel C. Nunes², Sergio Barrichello², Induja R. Nimma¹, Vivek Kumbhari¹, Dilhana S. Badurdeen^1
1Mayo Clinic in Florida, Jacksonville, FL; ²Angioskope, Sao Paulo, Brazil

834. PRE-OPERATIVE SERUM CREATININE PREDICTS MORBIDITY AND MORTALITY IN METABOLIC AND BARIATRIC SURGERY - AN MBSAQIP PROPENSITY SCORE MATCHED ANALYSIS
Steven M. Elzein*¹, Daniel Tomey¹, Sara Butt¹, Maria Corzo¹, Halil Bulut⁵, Sachin Shetty³, Suman Shetty⁸, Victor G. Peña¹, Roberto Secchi del Rio⁹, Nnenna A. Osagwu⁷, Victor Bolivar⁶, Adel Abou-Mrad⁴, Rodolfo J. Oviedo^2
1Surgery, Houston Methodist Hospital, Houston, TX; ²Nacogdoches Center for Metabolic and Weight Loss Surgery, Nacogdoches, TX; ³Baylor College of Medicine, Houston, TX; ⁴Centre Hospitalier Regional d'Orleans, Orleans, Centre-Val de Loire, France; ⁵Royal Brompton and Harefield Hospitals, London, United Kingdom; ⁶Universidad de Oriente, Cumana, Sucre, Venezuela, Bolivarian Republic of; ⁷All Saints University School of Medicine, Roseau, Saint George, Dominica; ⁸The University of Texas at Austin, Austin, TX; ⁹Universidad Anahuac Queretaro, Santiago de Queretaro, Querétaro, Mexico

835. TRENDS IN THE ADOPTION OF ROBOTIC GASTRECTOMY FOR GASTRIC CANCER
Shruti Koti*, Neda Amini, Martin S. Karpeh
Department of Surgery, Northwell Health, New Hyde Park, NY

836. THE USE OF SLEEVE GASTRECTOMY FOR ELDERLY AND FRAIL OBESE PATIENTS IS SAFE, AND IT RESOLVES THEIR COMORBIDITIES IN MOST CASES
Eliahu Y. Bekhor*^1,2, Nayyera Tibi^1,2, Noam Peleg^1,2, Hila Shmilovich^1,2, lisa cooper^1,2, boris kirstein^1,2, Issa Nidal^1,2
1Rabin Medical Center, Petah Tikva, Central, Israel; ²Tel Aviv University, Tel Aviv, Tel Aviv, Israel

837. RISK FACTORS FOR PULMONARY EMBOLISM IN POSTOPERATIVE PATIENTS: DEVELOPMENT OF A RISK ASSESSMENT TOOL FOR CLINICAL DECISION MAKING AND USE OF COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAPHY
Ilaria Caturegli*¹, Biqi Zhang¹, Baokun Gu², Bidisha Das¹, Mark M. Hammer¹, Jiping Wang^1
1Brigham and Women's Hospital, Boston, MA; ²Stanford University School of Medicine, Stanford, CA

838. SURVIVAL DIFFERENCES FOR PATIENTS WITH GASTRIC CANCER IN THE US AND BRAZIL: A CROSS-SECTIONAL ANALYSIS OF TWO NATIONAL DATASETS
Daniel J. Szor*², Kaleem S. Ahmed¹, Cibele Barbosa Carroll¹, Taylor Jaraczewski³, Francisco Tustumi², Ulysses Ribeiro², Noelle K. LoConte¹, Nataliya Uboha¹, Kaitlyn J. Kelly¹, Syed Nabeel Zafar^1
1Surgery, University of Wisconsin-Madison, Madison, WI; ²Universidade de Sao Paulo, Sao Paulo, Brazil; ³Medical College of Wisconsin, Milwaukee, WI

839. TRENDS IN NEOADJUVANT CHEMOTHERAPY UTILIZATION AND TREATMENT SEQUENCING FOR GASTRIC CANCER: ARE WE MAKING PROGRESS?
Alexandra E. Hernandez*, Yujie Wang, Jodie A. Barkin, Alan S. Livingstone, Mehmet Akcin, Cheng-Bang Chen, Laurence R. Sands, Jose M. Martinez, Danny Sleeman, Onur Kutlu
Surgery, University of Miami, Coral Gables, FL

840. A NOVEL TECHNIQUE OF ENDOSCOPIC MAGNETIC COMPRESSION IN GASTROSTOMY
Fei Xue*
General Surgery, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, China

841. DIFFERENCES IN PATIENT OUTCOMES CANNOT EXPLAIN HIGHER MORTALITY FROM GASTRIC ADENOCARCINOMA IN RACIAL/ETHNIC POPULATIONS: AN ANALYSIS OF THE NCDB
Alexandra Adams*¹, Brijesh Rana¹, Brett L. Ecker¹, Mariam F. Eskander¹, Timothy Kennedy¹, Miral S. Grandhi¹, Russell Langan¹, Henry A. Pitt¹, Haejin In^1,2
1Surgical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; ²Rutgers School of Public Health, Piscataway, NJ

842. MECHANISMS OF GASTROESOPHAGEAL REFLUX POST-ROUX-EN-Y GASTRIC BYPASS: UNIVERSAL ALTERATION OF THE ANTI-REFLUX BARRIER IS THE CULPRIT
Karim Al Annan*, Razan Nabeel Mousa Aburumman, Rudy Mrad, Khushboo Gala, Barham K. Abu Dayyeh
Gastroenterology and Hepatology, Mayo Clinic Minnesota, Rochester, MN

843. MINIMALLY INVASIVE SURGERY FOR GASTRIC ADENOCARCINOMA IS ASSOCIATED WITH BETTER SHORT-TERM OUTCOMES WITHOUT COMPROMISE IN LONG TERM AND ONCOLOGICAL OUTCOMES
Alexandra E. Hernandez*¹, Yujie Wang¹, Jodie A. Barkin², Alan S. Livingstone¹, Mehmet Akcin¹, Cheng-Bang Chen¹, Laurence R. Sands¹, Jose M. Martinez¹, Danny Sleeman¹, Onur Kutlu^1
1Surgery, University of Miami, Coral Gables, FL; ²University of Miami Miller School of Medicine, Miami, FL

844. BOTULINUM TOXIN PYLOROPLASTY TO REDUCE POST-OPERATIVE NAUSEA AND VOMITING AFTER SLEEVE GASTRECTOMY: A PILOT RANDOMIZED TRIAL
Grishma Pradhan*, Tyler Robinson, Ashar Ata, Tejinder P. Singh, Jessica Zaman
General Surgery, Albany Medical Center, Albany, NY

845. EFFICACY OF GPOEM (GASTRIC PERORAL ENDOSCOPIC MYOTOMY) FOR REFRACTORY GASTROPARESIS: A META-ANALYSIS
Vishal Chandel*¹, Veronica West², Neel Chandel^3
1Internal Medicine, Suburban Community Hospital, East Norriton, PA; ²Philadelphia College of Osteopathic Medicine, Philadelphia, PA; ³St Mary Medical Center, Langhorne, PA

846. THE SAFETY AND TECHNICAL FEASIBILITY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER AMONG PATIENTS ?75 YEARS OF AGE - A SYSTEMATIC REVIEW AND META-ANALYSIS
Maryam Rafaqat Hussain*², Faisal S. Ali¹, Brian Downer², Vaibhav Wadhwa¹, Tomas DaVee¹, Nirav Thosani^2
1The University of Texas Health Science Center at Houston, Houston, TX; ²The University of Texas Medical Branch at Galveston, Galveston, TX

847. PATHOLOGICAL COMPLETE RESPONSE (PCR) TO DURVALUMAB PLUS 5-FLUOROURACIL, LEUCOVORIN, OXALIPLATIN AND DOCETAXEL (FLOT) IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCER (GC/GEJC): REGIONAL SUBGROUP ANALYSIS FROM THE PHASE 3 MATTERHORN STUDY
Molena, Daniela¹*, Janjigian, Yelena², Al-Batran, Salah-Eddin³, Wainberg, Zev A.⁴, Van Cutsem, Eric⁵; Muro, Kei⁶; Hyung, Woo J.⁷; Wyrwicz, Lucjan⁸; Oh, Do-Youn⁹; Omori, Takeshi¹⁰; Moehler, Markus¹¹; Garrido, Marcelo¹²; Oliveira, Sulene C.¹³; Liberman, Moishe¹⁴; Castro Oliden, Victor¹⁵; Bilici, Mehmet¹⁶; Kurland, John F.¹⁷; Xynos, Ioannis¹⁸; Mann, Helen¹⁸; Tabernero, Josep^19
1Division of Thoracic Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States; ²Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States; ³Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt, Germany; ⁴Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; ⁵Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium; ⁶Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan; ⁷Department of Surgery, Yonsei University College of Medicine, Seoul, Korea (the Republic of); ⁸Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland; ⁹Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea (the Republic of); ¹⁰Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan; ¹¹Research Center for Immunotherapy (FZI), Johannes Gutenberg-University Clinic, Mainz, Germany; ¹²SAGA Clinical Trial Centre and Universidad Mayor, Santiago, Chile; ¹³Clinical Oncology, The Clinical Research Center, Northern Riograndense League Against Cancer, Natal, Rio Grande do Norte, Brazil; ¹⁴Division of Thoracic Surgery, Department of Surgery, Centre Hospitalier de l'Université de Montréal, Centre de Recherche du CHUM, Montréal, QC, Canada; ¹⁵National Institute of Neoplastic Diseases (INEN), Lima, Peru; ¹⁶Department of Medical Oncology, Atatürk University Faculty of Medicine, Erzurum, Turkey; ¹⁷AstraZeneca, Gaithersburg, MD, United States; ¹⁸AstraZeneca, Cambridge, None Selected, United Kingdom; ¹⁹Medical Oncology Department, Vall d’Hebron Hospital Campus & Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain

Faculty:

Eduardo Vilar-Gomez, Indianapolis, IN Cynthia Moylan, Durham, NC

Sp870
FROM NAFLD TO MASLD: MORE THAN JUST A NEW ABBREVIATION
Tania Mitsinikos
University of Southern California, Los Angeles, CA

Sp871
CHALLENGES AND OPPORTUNITIES FOR MASLD DETECTION AND RISK STRATIFICATION
Mohammad Shadab Siddiqui
Virginia Commonwealth University Health System, Richmond, VA

Sp872
PHARMACOLOGIC APPROACHES TO MASLD TREATMENT
Kathleen E. Corey
Massachusetts General Hospital, Boston, MA

Sp873
NON-PHARMACOLOGIC THERAPIES FOR MASLD: LIFESTYLE, ENDOBARIATRICS, AND BARIATRIC SURGERY
Violeta Popov
Medicine, NYU Langone Health, New York, NY

Sp874
ADDRESSING ACCESS AND HEALTH DISPARITIES FOR MASLD ACROSS THE CLINICAL AND RESEARCH SPECTRUM
Nicole E. Rich
Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX

Faculty:

Sachiyo Nomura, Tokyo, Japan Brian Davis, El Paso, TX Karen Gibbs, New Haven, CT

948. DIABETES MICROVASCULAR AND MACROVASCULAR COMPLICATIONS PREDICT DIABETES REMISSION AFTER BARIATRIC SURGERY
Wissam Ghusn*^2,1, Marita Salame², Karl Hage², Khushboo Gala², Andrew C. Storm², Barham K. Abu Dayyeh², Andres Acosta², Omar M. Ghanem^2
1Internal Medicine, Boston University, Boston, MA; ²Mayo Foundation for Medical Education and Research, Rochester, MN

949. ORAL MICROBIOME SIGNATURES AS POTENTIAL BIOMARKERS FOR GASTRIC CANCER RISK ASSESSMENT
Shruthi R. Perati*¹, Mykhaylo Usyk², Alexandra Adams³, Brijesh Rana³, Julie Yang⁴, Srawani Sarkar², Fei Wang², Laurence P. Diggs⁵, Christopher C. Sollecito², Robert D. Burk², Haejin In^3
1Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; ²Department of Pediatric (Genetic Medicine), Albert Einstein College of Medicine, Bronx, NY; ³Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ; ⁴Division of Gastroenterology, Mount Sinai Hospital, New York, NY; ⁵Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

950. EFFICACY OF GASTRIC-STIMULATOR AS AN ADJUNCT TO PYLOROPLASTY FOR GASTROPARESIS: CHARACTERIZING PATIENTS SUITABLE FOR SINGLE-PROCEDURE VS DUAL PROCEDURE APPROACH
Sven Eriksson*¹, Margaret Gardner¹, Inanc Sarici¹, Ali H. Zaidi¹, Ping Zheng¹, Blair Jobe^1,2, Shahin Ayazi^1,2
1Esophageal Institute, Department of Surgery, Allegheny Health Network, Pittsburgh, PA; ²Department of Surgery, Drexel University College of Medicine, Philadelphia, PA

951. EFFECTS OF BARIATRIC SURGERY ON MORTALITY AND INPATIENT COMPLICATIONS IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE ANALYSIS
Stephen A. Firkins*, Yazan Abu Omar, Roma Patel, Heesoo Yoo, Alvin Kwon, Bailey Flora, Jeffrey Shu, Alison Zhao, Meghana Iyer, Roberto Simons-Linares
Gastroenterology, Cleveland Clinic, Cleveland, OH

952. GASTRIC POLYPOSIS AND RISK OF GASTRIC CANCER IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP) SYNDROME
Rachel V. Christenson*¹, Shubham Sood², Robert A. Vierkant³, Daniel Schupack², Lisa Boardman², Travis E. Grotz^4
1Mayo Clinic Department of Surgery, Rochester, MN; ²Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN; ³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN; ⁴Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN

953. MAGETIC SPHINCTER AUGMENTION VERSUS SUBTOTAL GASTRECTOMY WITH ROUX-EN-Y RECONSTRUCTION FOR THE TREATMENT OF POST-SLEEVE GASTRECTOMY GASTROESOPHAGEAL REFLUX DISEASE
Rachel S. Jefferies*^1,2, Marc Ward^1,3, Rehma Shabbir¹, Daylon Farias^1,2, Gerald Ogola¹, Steven G. Leeds^1,3
1Baylor Scott & White Health, Dallas, TX; ²University of North Texas Health Science Center, Fort Worth, TX; ³Baylor University Medical Center at Dallas, Dallas, TX

Faculty:

Jacquelyn Turner, New Orleans, LA V. Prasad Poola, Springfield, IL Tsuyoshi Konishi, Houston, TX

942. TREATMENT OF RECTAL CANCER BY TOTAL NEOADJUVANT THERAPY AND TRANSANAL LIMITED LOCAL EXCISION FOR COMPLETE RESPONDERS: PHASE II TRIAL RESULTS
Jasneet S. Bhullar*², Amer Alame¹, Ernesto Drelichman², Mohammed Barawi¹, Amer Zeni², Zyad Kafri¹, Elon Knoll³, Yakan Adli², Wajahat Khan³, Amr Aref^1
1Ascension St John Hospital, Detroit, MI; ²Ascension Providence Hospital Southfield Campus, Southfield, MI; ³Ascension Macomb-Oakland Hospital Warren Campus, Warren, MI

943. THE MICROBIOTA AT THE TIME OF SURGERY IS SIGNIFICANTLY ENRICHED WITH PRO-TUMORIGENIC BACTERIA IN PATIENTS WHO DEVELOP A POSTOPERATIVE RECURRENCE
Meejeon Roh, Mohsen Rouhani Ravari*, Claire Wild, Mason Vierra, Ryan B. Morgan, Lindsay Alpert, Nicholas R. Suss, Olga Zaborina, Benjamin D. Shogan
University of Chicago Division of the Biological Sciences, Chicago, IL

944. CAN TUMOR RESPONSE TO INDUCTION CHEMOTHERAPY PREDICT TME-FREE SURVIVAL AFTER TOTAL NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RECTAL CANCER?
Hussein K. Gharib*, Susan Szpunar, Zyad Kafri, Elon Knoll, Wajahat Khan, Adli Yakan, Mohammed Barawi, Ernesto Drelichman, Amer Alame, Amer Zeni, Amr Aref
Hematology/Oncology, Ascension St John Hospital, Detroit, MI

945. SHOULD THE ADENOMA DETECTION RATE QUALITY METRIC VARY BY AGE: AN EXPLORATORY ANALYSIS
Charmee Mehta*, Dmitry Tumin, Michael Honaker
Surgery, East Carolina University, Greenville, NC

946. DOES SURGERY FOR IBD DELIVER ON IT'S PROMISES? IMPACT OF SURGERY ON SHORT-TERM PATIENT REPORTED OUTCOMES FROM THE CROHN'S & COLITIS FOUNDATION'S SURGICAL INNOVATIONS, RESEARCH, & QUALITY COLLABORATIVE
Stefan D. Holubar*¹, Samuel Eisenstein², Karen Zaghiyan⁵, Kinga S. Olortegui⁴, Muneera Kapadia⁷, Sarah Stringfield⁶, Alessandro Fichera⁶, Phillip Fleshner⁵, Neil Hyman⁴, Roger D. Hurst⁴, Jeremy M. Lipman¹, Nicole Lopez², Lisa A. Parry², Benjamin D. Shogan⁴, Jonathan Stem⁷, Sonia Ramamoorthy², Katerina O. Wells⁶, Caroline Perry³, Megan Villarreal³, Alandra Weaver³, Caren Heller^3
1Colon and Rectal Surgery, Cleveland Clinic, Cleveland, OH; ²University of California San Diego, La Jolla, CA; ³Crohn's & Colitis Foundation, New York, NY; ⁴University of Chicago Pritzker School of Medicine, Chicago, IL; ⁵Cedars-Sinai Medical Center, Los Angeles, CA; ⁶Baylor Scott & White Health, Dallas, TX; ⁷The University of North Carolina at Chapel Hill, Chapel Hill, NC

947. IMPACT OF PREOPERATIVE USE OF BIOLOGICS ON 30-DAY SURGICAL MORBIDITY AND MORTALITY IN PATIENTS WITH CROHN'S DISEASE UNDERGOING ILEOCOLECTOMY: NSQIP DATABASE ANALYSIS
Fady Daniel*, Mohamad Ali Ibrahim, Zakaria El Kouzi, Mohamad Khalife, Walaa G. El Sheikh, Hani Tamim
Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

Sp933
Carlos A. Pellegrini
Chair, University of Washington, Seattle, Washington

Nathaniel J. Soper
Surgery, University of Arizona College of Medicine-Phoenix, Phoenix, AZ

Interviewer:	Vic Velanovich, USF, Tampa, FL
Panelists:	Allison N. Martin, Surgical Oncology, The University of Texas MD Anderson Cancer Center Division of Surgery, Houston, TX Jenny H. Chang, Surgery, Cleveland Clinic, Cleveland, OH

Moderator:

Vic Velanovich, Tampa, FL

Sponsored by: AGA, AASLD, ASGE, SSAT

Moderators:

Michael Kochman, Philadelphia, PA Scott Fraser, Malvern, PA

Sp936
WELCOME AND SHARK INTRODUCTIONS
Michael Kochman, Philadelphia, PA
Scott Fraser, Malvern, PA

Sp937
AASLD SHARK
Scott Friedman

SP938
AGA SHARK
Naresh Gunaratnam

Sp939
ASGE SHARK
Nalini Guda

Sp940
SSAT SHARK
Brian Dunkin

Sp941
AASLD INNOVATOR
Patricia Bloom

Sp942
AGA INNOVATOR
Renumathy Dhanasekaran
Vetri Venthan Elango

Sp943
ASGE INNOVATOR
Jianhua Tau

SP944
SSAT INNOVATOR
Bara El Kurdi

Faculty:

Sergio Bardaro, Cleveland, OH Ronnie Fass, Beachwood, OH Alia Qureshi, Portland, OR

Sp948
TYPES OF GASTROPARESIS PATIENTS
Michael Sarr
Surgery, Mayo Clinic, Cave Creek, AZ

Sp949
EVALUATION OF GASTROPARESIS
Henry P. Parkman
Temple Univ School of Medicine, Philadelphia, PA

Sp950
MEDICAL MANAGEMENT OF GASTROPARESIS
Michael Camilleri
Mayo Clinic College of Medicine, Rochester, MN

Sp951
ENDOSCOPIC TREATMENT OF GASTROPARESIS
Kevin El-Hayek
MetroHealth Medical Center, Cleveland, OH

Sp952
SURGICAL TREATMENT OF GASTROPARESIS
Brian R. Davis
Texas Tech Health Sciences Center E, El Paso, TX